Literature DB >> 8841326

Acute stroke with atrial fibrillation. The Copenhagen Stroke Study.

H S Jørgensen1, H Nakayama, J Reith, H O Raaschou, T S Olsen.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is a common arrhythmia and a major risk factor for stroke. Many physicians remain reluctant to provide stroke prevention by anticoagulant therapy especially for elderly individuals with AF. Using multivariate regression analyses, we studied the characteristics and the prognosis of stroke in patients with AF.
METHODS: The study is part of the Copenhagen Stroke Study, a prospective, community-based study of 1197 patients with acute stroke treated on a stroke unit from the time of acute admission to the end of rehabilitation. Initial stroke severity was measured by the Scandinavian Neurological Stroke Scale (SSS). Neurological and functional outcomes were evaluated by the SSS and the Barthel Index.
RESULTS: AF was diagnosed in 18% of the patients. AF increased steeply with age in the stroke population, from 2% in patients < 50 years old, 15% in patients in their 70s, and 28% in patients in their 80s, to 40% in patients > or = 90 years of age. In a multivariate analysis AF was associated with age (odds ratio [OR], 2.0 per 10-year increase; 95% confidence ratio [CI], 1.6 to 2.6), ischemic heart disease (OR, 3.4; 95% CI, 2.4 to 4.8), previous stroke (OR, 1.8; 95% CI, 1.2 to 2.6), and systolic blood pressure (OR, 0.93 per 10-mm Hg increases; 95% CI, 0.88 to 0.99), but not with sex, diabetes, hypertension, previous transient ischemic attack, or silent infarction on computed tomography. Patients with AF had a higher mortality rate (OR, 1.7; 95% CI, 1.2 to 2.5), longer hospital stays (50 days versus 40 days, P < .001), and a lower discharge rate to their own homes (OR, 0.60; 95% CI, 0.44 to 0.85). Neurological and functional outcomes were markedly poorer in patients with AF. Poorer outcome was exclusively explained by initially more-severe strokes.
CONCLUSIONS: Stroke in patients with AF is generally more severe and outcome markedly poorer than in patients with sinus rhythm. This accentuates the importance of anticoagulant treatment of individuals with AF. A lower blood pressure in the acute stage of stroke may contribute to the increased stroke severity in patients with AF.

Entities:  

Mesh:

Year:  1996        PMID: 8841326     DOI: 10.1161/01.str.27.10.1765

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  110 in total

1.  Relationship between left atrial spontaneous echo contrast and the features of middle cerebral artery territory in nonvalvular atrial fibrillation.

Authors:  K Kochi; K Kanehiro; K Mukada; J Hasada; S Kajihara; K Orihashi; T Sueda; Y Matsuura
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

2.  Long term anticoagulation or antiplatelet treatment. Only warfarin has been shown to reduce stroke risk in patients with atrial fibrillation.

Authors:  J G Cleland; G C Kaye
Journal:  BMJ       Date:  2001-07-28

Review 3.  Very low-intensity antithrombotic therapy in atrial fibrillation.

Authors:  B G Koefoed; P Petersen
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

Review 4.  Atrial fibrillation (chronic).

Authors:  Deirdre A Lane; Stavros Apostolakis; Christopher J Boos; Gregory Y H Lip
Journal:  BMJ Clin Evid       Date:  2011-11-10

Review 5.  Promise of factor Xa inhibition in atrial fibrillation.

Authors:  Sana M Al-Khatib; John H Alexander; Renato D Lopes; Kenneth W Mahaffey; Manesh R Patel; Christopher B Granger
Journal:  Curr Cardiol Rep       Date:  2012-02       Impact factor: 2.931

6.  [Outcome parameters for AF trials--executive summary of an AFNET-EHRA consensus conference].

Authors:  P Kirchhof; A Goette; G Hindricks; S Hohnloser; K-H Kuck; T Meinertz; U Ravens; G Steinbeck; G Breithardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-12

7.  Optimal delay time to initiate anticoagulation after ischemic stroke in atrial fibrillation (START): Methodology of a pragmatic, response-adaptive, prospective randomized clinical trial.

Authors:  Benjamin T King; Patrick D Lawrence; Truman J Milling; Steven J Warach
Journal:  Int J Stroke       Date:  2019-08-18       Impact factor: 5.266

8.  Evaluation of anticoagulation use and subsequent stroke in patients with atrial fibrillation after empiric surgical left atrial appendage closure: A retrospective case-control study.

Authors:  Daniel O Johnsrud; Rowlens M Melduni; Brian Lahr; Xiaoxi Yao; Kevin L Greason; Peter A Noseworthy
Journal:  Clin Cardiol       Date:  2018-12-10       Impact factor: 2.882

9.  Intravenous heparin dosing strategy in hospitalized patients with atrial dysrhythmias.

Authors:  Robert O Roswell; Brian Greet; Sunny Shah; Samuel Bernard; Alexandra Milin; Iryna Lobach; Yu Guo; Martha J Radford; Jeffrey S Berger
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

10.  Atrial fibrillation in patients with ischemic stroke: A population-based study.

Authors:  Sandra Kruchov Thygesen; Lars Frost; Kim A Eagle; Søren Paaske Johnsen
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.